Overview
No overview information available.
Indication
对常规放疗或放疗加化疗治疗无效，并以5-FU、顺铂化疗方案进行姑息治疗的晚期鼻咽癌患者可试用本品与前述化疗方案联合使用。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/04/09 | Phase 2 | Not yet recruiting | |||
2024/09/30 | Phase 2 | Not yet recruiting | |||
2024/06/12 | Phase 2 | Recruiting | |||
2024/02/12 | Phase 2 | Not yet recruiting | First Affiliated Hospital Bengbu Medical College | ||
2024/01/09 | Phase 2 | Not yet recruiting | |||
2023/07/03 | Phase 1 | ENROLLING_BY_INVITATION | |||
2023/04/21 | Phase 2 | Recruiting | |||
2023/01/09 | Phase 1 | Recruiting | |||
2022/03/31 | Phase 1 | Completed | |||
2022/03/31 | Phase 1 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| 重组人5型腺病毒注射液 | 国药准字S20060027 | 生物制品 | 注射剂 | 11/11/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.